<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The anti-CD20 monoclonal antibody rituximab is an effective treatment for small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; however, it has been associated with infusion reactions, including <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Severe <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> is an adverse reaction that is related to rituximab chemotherapy, and more investigation is warranted into the adverse reactions of rituximab that involve <z:hpo ids='HP_0011675'>cardiac conduction abnormalities</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we report what we believe to be the 1st case of symptomatic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> to have occurred during an initial infusion of rituximab </plain></SENT>
</text></document>